Results 221 to 230 of about 168,682 (384)

I04. Blocking B-Cells (Anti-CD20/Anti-CD20) [PDF]

Rheumatology, 2015
openaire   +2 more sources

The importance of tumor microenvironment modulations in the progression of pancreatic intraductal papillary mucinous neoplasms†

The Journal of Pathology, EarlyView.
Abstract Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas have attracted substantial attention since they represent the most prevalent macroscopic precursor of pancreatic cancer. Most lesions show an epithelium with low‐grade dysplasia and will remain indolent and unknown to the patient.
Antonio Pea, Claudio Luchini
wiley   +1 more source

Reproductive adverse events in patients with non‐Hodgkin lymphoma treated with chemotherapeutic regimens including cyclophosphamide, doxorubicin, vincristine, prednisone or CHOP with rituximab: A systematic review and meta‐analysis

Pediatric Discovery, EarlyView.
The regimen of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R‐CHOP) is the first‐line treatment for non‐Hodgkin lymphoma (NHL). Nine articles involving 331 patients were included in the meta‐analysis, the pooled proportion of reproductive adverse events was 22.3% (95% CI 11.4%–33.2%; p < 0.001). The findings
Rong Han, Jie Zhao, Chengjun Yu, Ling Wang, Long Chen, Yang Hu, Shengde Wu   +6 more
wiley   +1 more source

Sustained response of refractory chronic lymphocytic leukemia in progression complicated by acute hemolitic anemia to anti-CD20 monoclonal antibody [PDF]

, 2002
Emilio Iannitto, Emanuele Ammatuna, C Marino, Sonia Cirrincione, Gioacchino Greco, G Mariani   +5 more
openalex   +1 more source

Resolving the structural basis of therapeutic antibody function in cancer immunotherapy with RESI. [PDF]

Nat Commun
Pachmayr I, Masullo LA, Reinhardt SCM, Kwon J, Llop M, Skořepa O, Herter S, Bacac M, Klein C, Jungmann R.   +9 more
europepmc   +1 more source

Potential roles of antibodies with different classes in IgG4‐related diseases

Rheumatology &Autoimmunity, EarlyView.
This review discussed the common characteristics of different classes of antibodies and their potential corresponding unique mechanisms involved in immunoglobulin G4‐related disease. Abstract Immunoglobulin G4‐related disease (IgG4‐RD), first identified two decades ago, is an immune‐mediated pro‐inflammatory and profibrotic disease entity affecting ...
Ling Li, Shaozhe Cai, Shengyan Lin, Lin Bai, Zhihua Yu, Wei Sun, Lingli Dong   +6 more
wiley   +1 more source

Long-term remission of Kaposi sarcoma–associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy

, 2001
Mario Corbellino, Giovanna Bestetti, Chiara Scalamogna, Sara Calattini, Morena Galazzi, Luca Meroni, Daniele Manganaro, Marco Fasan, Mauro Moroni, Massimo Galli, Carlo Parravicini   +10 more
openalex   +1 more source

CHILDHOOD REFRACTORY AUTOIMMUNE HAEMOLYTIC ANAEMIA: IS THERE A ROLE FOR ANTI‐CD20 THERAPY (RITUXIMAB)? [PDF]

, 2002

openalex   +1 more source

CD20+ T Cells in Multiple Sclerosis: From Pathogenesis to Treatment-Induced Depletion. [PDF]

Int J Mol Sci
Mazzeo AC, Calabresi L, Damato V, Spagni G, Massacesi L, Mariottini A.   +5 more
europepmc   +1 more source

Bilateral primary adrenal lymphoma

Journal of General and Family Medicine, EarlyView.
Rio Shimizu, Shogo Shirota
wiley   +1 more source